Pfizer Venture Investments (investor - Corporate Investor)

See something wrong or missing? Let us know

Pfizer Venture Investments (PVI), the venture capital arm of Pfizer, Inc, was founded in 2004 and invests for return in areas of current or future strategic interest to Pfizer. PVI seeks to remain at the forefront of life science advances, looking to identify and invest in emerging companies that are developing compounds and technologies that have the potential to enhance Pfizer’s pipeline and shape the future of our industry.

With a $50M annual budget for private investments, PVI may invest up to $10M per round in selected companies in any stage of development, with a strong focus on growth stage opportunities. Other investments, including fund investing, spinout opportunities, and PIPEs will also be considered as appropriate. We actively manage our current portfolio and are seeking to make new investments.

Average round investment:46.77M USD
Average number per year:2.6
Distribution: 2025 (1)2024 (6)2023 (2)2022 (5)2021 (2) See the entire list
Mostly invests in: United Kingdom United Kingdom (10) Health services (18)
See the entire list

Showing 3 of 18 tracked investments in:


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Pfizer Venture Investments mostly invests with:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Pfizer Venture Investments

Name Criteria
Belgium V-Bio Ventures
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: Belgium
  • Average number of deals per year: 2.6
  • Active last 12 months: Yes
Switzerland Novartis Venture Fund
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Pharma, Manufacturing, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom, Switzerland, Ireland
  • Average number of deals per year: 2.7
  • Active last 12 months: Yes
Switzerland ABB Technology Ventures (ATV)
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Software Services, AI (big data)
  • Similar business models: B2B
  • Common investees countries: United Kingdom, Switzerland, Ireland, Sweden
  • Average number of deals per year: 2.8
  • Active last 12 months: Yes
United Kingdom Aviva Ventures
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Manufacturing, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom, Ireland
  • Average number of deals per year: 2.4
  • Active last 12 months: Yes
United States Base10 Partners
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Software Services, AI (big data)
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.3
  • Active last 12 months: Yes
United States Adjuvant Capital
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Pharma, Manufacturing
  • Similar business models: B2B
  • Common investees countries: United Kingdom, Switzerland, Belgium
  • Average number of deals per year: 2.2
  • Active last 12 months: Yes
Netherlands Icos Capital Management
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Pharma, Manufacturing, Software Services
  • Similar business models: B2B
  • Common investees countries: United Kingdom
  • Average number of deals per year: 2.2
  • Active last 12 months: Yes
United Kingdom Expedition Growth Capital
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Manufacturing, Software Services, AI (big data)
  • Similar business models: B2B
  • Common investees countries: Sweden
  • Average number of deals per year: 3.0
  • Active last 12 months: Yes
Belgium Korys
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Software Services, AI (big data)
  • Similar business models: B2B
  • Common investees countries: Belgium, Sweden
  • Average number of deals per year: 2.1
  • Active last 12 months: Yes
Germany Yabeo
83%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Health services, Biotech, Manufacturing, Software Services, AI (big data)
  • Similar business models: B2B
  • Common investees countries: United Kingdom, Sweden
  • Average number of deals per year: 3.0
  • Active last 12 months: Yes
Top